Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

MFC Co., Ltd.

엠에프씨432980KOSDAQSector: Pharma & Biotech
₩2,5150.40%Market cap ₩21.6BAs of Sep 2, 2026 close · updated once daily
Market cap
₩21.6B
#1597 in KOSDAQ
26.4x
Sector median 16.3x (profitable cos.)
0.72x
Sector median 1.61x
0.0%
Sector median 0.0%
B
Grade B57.6 ptsTop 40% of 2,523 graded stocksMethodology v2.0

As of Sep 2, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 57.6 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩2,480High ₩4,230
Latest close
Price change by period
1W
0.50%
1M
0.90%
3M
4.30%
1Y
32.90%

As of the Sep 2, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

66.8/100
How much debt does it carry relative to equity?
18.7%
Sector median 51.6%
Sector lowhighTop 21.3% in sector
Can it cover what's due within a year?
359.0%
Sector median 191.7%
Sector lowhighTop 32.2% in sector
How much of revenue becomes profit?
1.4%
Sector median -2.4%
Sector lowhighTop 43.6% in sector
How much did it earn on its own capital?
2.7%
Sector median -4.5%
Sector lowhighTop 35.8% in sector

Source filing: annual report (separate) — view original

2

Growth momentum

23.7/100
How much did revenue grow in a year?
0.9%
Sector median 6.4%
Sector lowhighBottom 36.1% in sector
Did core profits grow in a year?
-79.7%
Sector median 3.6%
Sector lowhighBottom 11.3% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original

3

Price attractiveness

74.3/100
Is the price expensive relative to earnings?
26.4x
Sector median P/E of profitable peers 16.3x · 58% loss-making
Sector lowhighTop 27.3% in sector
Is the price expensive relative to book value?
0.72x
Sector median 1.61x
Sector lowhighTop 24.1% in sector

Valuation uses the Sep 2, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Dividends & treasury shares

Treasury shares (FY2025)
515,670 shares (6.0% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (separate) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 6 met · 1 not met · 2 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩822M
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩2.4B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩2.4B vs ₩822M
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
22.2% → 15.8%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
277.0% → 359.0%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
8,591,742 → 8,591,742
Operating margin up
Whether operating income over revenue rose from the prior year.
Not met
7.1% → 1.4%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not computable

Not computed — required financial data is unavailable

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source
Treasury stock acquisitionJun 15, 2026Source
Periodic report filedMay 15, 2026Source

View in the filings calendar →